[Chinese expert consensus on multidisciplinary management of type 2 diabetes mellitus complicated with metabolic-dysfunction associated steatotic liver disease (2026 edition)].

Type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) are closely related to each other, and their bidirectional pathophysiological interactions significantly increase the risks of liver-related and extrahepatic adverse outcomes. Multidisciplinary management is essential to improve long-term outcomes and the overall quality of integrated care in individuals with T2DM and MASLD. The expert consensus "Chinese expert consensus on multidisciplinary management of type 2 diabetes mellitus complicated with metabolic-dysfunction associated steatotic liver disease (2026 edition)" was developed by multidisciplinary experts from Chinese Society of Health Management, Liver and Gallbladder Diseases Branch of China Association of Chinese Medicine and Liver Health Consortium in China (CHESS). By integrating expertise across specialties, a systematic and continuous care model can be established encompassing early screening, precision diagnosis, risk stratification, individualized interventions, and long-term management. Such an approach can optimize coordinated management strategies for T2DM and MASLD and improve quality of life and long-term survival.